The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: A European perspective

Kidney International

Volumn 70, Issue SUPPL. 103, 2006, Pages

  Khalifeh, N ^a   Vychytil, A ^a   Horl W H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Congestive heart failure; Fluid overload; Peritoneal dialysis; Treatment resistance; Ultrafiltration

Indexed keywords

DIURETIC AGENT;

CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE SEVERITY; HEMODIALYSIS; HEMOFILTRATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LONG TERM CARE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAFILTRATION; EUROPE;

EUROPE; HEART FAILURE, CONGESTIVE; HUMANS; PERITONEAL DIALYSIS;

EID: 39049174875     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001919     Document Type: Article

References (59)

1. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin 2001; 19: 547-555.
2. Shlipak MG, Smith GL, Rathore SS et al. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 2004; 15: 2195-2203.
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
5. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-1355.
6. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
7. Hjalmarson A, Goldstein S, Fagerberg B et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
8. Packer M, Coats AJ, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
9. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
10. Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.
11. Faris R, Flather M, Purcell H et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002; 82: 149-158.
12. Schneierson SJ. Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin. Am J Med Sci 1949; 218: 76-79.
13. Kolff WJ, Leonards JR. Reduction of otherwise intractable edema by dialysis or filtration. Cleve Clin Q 1954; 21: 61-71.
14. Bertrand E, Guerin J. Peritoneal dialysis with glucose in the treatment of the irreducible edemas of cardiac patients. Med Trop 1961; 21: 603-606.
15. Burns RO, Henderson LW, Hager EB et al. Peritoneal dialysis. Clinical experience. N Engl J Med 1962; 267: 1060-1066.
16. Bercu B, Heinz JN, Anderson R. Treatment of congestive failure with peritoneal dialysis. J Mich State Med Soc 1963; 62: 1105-1107.
17. Mailloux LU, Swartz CD, Onesti G et al. Peritoneal dialysis for refractory congestive heart failure. JAMA 1967; 199: 873-878.
18. König P, Geissler D, Lechleitner P et al. Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med 1987; 147: 1031-1034.
19. Elhalel-Dranitzki M, Rubinger D, Moscovici A et al. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 1998; 13: 3041-3042.
20. Stegmayr BG, Banga R, Lundberg L et al. PD treatment for severe congestive heart failure. Perit Dial Int 1996; 16(Suppl 1): S231-S235.
21. Ryckelynck JP, Lobbedez T, Valette B et al. Peritoneal ultrafiltration and refractory congestive heart failure. Adv Perit Dial 1997; 13: 93-97.
22. Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Intern Med 1986; 146: 1533-1535.
23. König P, Lhotta K, Neyer U et al. Kontinuierliche ambulante Peritoneal-dialyse als Überbrückung zur Herztransplantation. Nieren-und Hoch-druckkrankheiten 1997; 26(Suppl 1): S55-S59.
24. Parvathaneni LS, Gugleilmi K, Silver MA. Difficult cases in heart failure: role of continuous ambulatory peritoneal dialysis in refractory heart failure. Congest Heart Fail 1999; 5: 283-285.
25. Ortiz AM, Acosta PA, Corbalan R et al. Long-term automated peritoneal dialysis in patients with refractory congestive heart failure. Adv Perit Dial 2003; 19: 77-80.
26. Shapira J, Lang R, Jutrin I et al. Peritoneal dialysis in refractory congestive heart failure part I: intermittent peritoneal dialysis (IPD). Perit Dial Bull 1983; 3: 130-132.
27. Kagan A, Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 2005; 20(Suppl 7): vii28-vii31.
28. Kim D, Khanna R, Wu G et al. Successful use of continuous ambulatory peritoneal dialysis in refractory heart failure. Perit Dial Bull 1985; 5: 127-130.
29. Mehrotra R, Khanna R. Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future. Cardiology 2001; 96: 177-182.
30. Robson M, Biro A, Knobel B et al. Peritoneal dialysis in refractory congestive heart failure. Part II: Continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; 3: 133-134.
31. Weinrauch LA, Kaldany A, Miller DG et al. Cardiorenal failure: treatment of refractory biventricular failure by peritoneal dialysis. Uremia Invest 1984; 8: 1-8.
32. McKinnie JJ, Bourgeois RJ, Husserl FE. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 1985; 145: 1128-1129.
33. Mousson C, Tanter Y, Chalopin JM et al. Treatment of refractory congestive cardiac insufficiency by continuous peritoneal dialysis. Long-term course. Presse Med 1988; 17: 1617-1620.
34. König PS, Lhotta K, Kronenberg F et al. CAPD: a successful treatment in patients suffering from therapy-resistant congestive heart failure. Adv Perit Dial 1991; 7: 97-101.
35. Mcligeyo SO. Intermittent peritoneal dialysis in the management of refractory heart failure. Cent Afr J Med 1992; 38: 421-424.
36. Tormey V, Conlon PJ, Farrell J et al. Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. QJM 1996; 89: 681-683.
37. Ryckelynck JP, Lobbedez T, Valette B et al. Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998; 13(Suppl 4): 56-59.
38. Freida P, Ryckelynck JP, Potier J et al. Place de l'ultrafiltration péritonéale dans le traitment bédical de l'insuffisance cardiaque au stade IV de la NYHA. Bull Dial Périt 1995; 5: 7-18.
39. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979-986.
40. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57: 2546-2556.
41. Bertoli SV, Ciurlino D, Maccario M et al. Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease. Adv Perit Dial 2005; 21: 123-127.
42. Hamburger RJ, Kraus MA. Icodextrin fulfills unment clinical need of PD patients: Improved ultrafiltration. Dial Transplant 2003; 32: 675-680.
43. Wolfson M, Piraino B, Hamburger RJ et al. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40: 1055-1065.
44. Araujo Teixeira MR, Pecoits-Filho RF, Romao Junior JE et al. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 2002; 22: 229-233.
45. Finkelstein F, Healy H, Abu-Alfa A et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16: 546-554.
46. Abu-Alfa AK, Burkart J, Piraino B et al. Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int 2002; 62(Suppl 81): S8-S16.
47. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957.
48. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2344.
49. Gotloib L, Fudin R, Yakubovich M et al. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005; 20(Suppl 7): vii32-vii36.
50. Parfrey PS, Harnett JD, Griffiths SM et al. Congestive heart failure in dialysis patients. Arch Intern Med 1988; 148: 1519-1525.
51. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992-1000.
52. Rubinger D. Management of refractory congestive heart failure - a nephrological challenge. Nephrol Dial Transplant 2005; 20(Suppl 7): vii37-vii40.
53. Stack AG, Molony DA, Rahman NS et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071-1079.
54. Konings CJ, Kooman JP, Schonck M et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003; 18: 797-803.
55. Costanzo MR, Saltzberg M, O'Sullivan J et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46: 2047-2051.
56. Bart BA, Boyle A, Bank AJ et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005; 46: 2043-2046.
57. Marenzi G, Lauri G, Grazi M et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38: 963-968.
58. Bourge RC, Tallaj JA. Ultrafiltration: a new approach toward mechanical diuresis in heart failure. J Am Coll Cardiol 2005; 46: 2052-2053.
59. Boyle A. Ultrafiltration for acute decompensated heart failure. Expert Rev Med Devices 2005; 2: 689-697.